Trials / Conditions / S. Aureus Bacteremia

S. Aureus Bacteremia

3 registered clinical trials studyying S. Aureus Bacteremia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia NCT06650501	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 4
Recruiting	Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia NCT06637332	Todd C. Lee MD MPH FIDSA	Phase 4
Terminated	Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bactere NCT01104662	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 4